Author Archives: Inês Martins PhD

FDA Approves Darzalex Faspro as Injection Therapy for Multiple Myeloma

The U.S. Food and Drug Administration (FDA) approved Janssen‘s new formulation of daratumumab — a subcutaneous or under-the-skin injection treatment called Darzalex Faspro (daratumumab and hyaluronidase) — as a faster and easier alternative for people with multiple myeloma. The original formulation, Darzalex, requires an intravenous (into-the-vein)…

ChemioCare Developing New Lenalidomide Skin Patch

Aiming to improve lenalidomide‘s safety and efficacy, ChemioCare is setting up to develop a new treatment formulation delivered through a skin patch, maintaining an optimal blood level of the medicine for prolonged periods of time. The new formulation uses the company’s permeation-enhanced transdermal technology (PETT), which “works like a continuous…